Testing earlier may yield unreliable results
These steps are essential to managing and preventing semaglutide-induced rash, allowing you to continue your treatment with minimal skin issues
This guide breaks down the real timeline of GLP-1 side effects based on clinical evidence and patient experience
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
She asserts that these injuries led to significant pain, vomiting, and medical intervention, ultimately forcing her to discontinue the drug